Cervical cancer incidence in young women: A historical and geographic controlled UK regional population study

British Journal of Cancer

Volumn 106, Issue 11, 2012, Pages 1753-1759

  Patel, A ^a   Galaal, K ^a   Burnley, C ^b   Faulkner, K ^b   Martin Hirsch, P ^c   Bland, M J ^d   Leeson, S ^e   Beer, H ^f   Paranjothy, S ^f,g   Sasieni, P ^h   Naik, R ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b The North East   (United Kingdom)

^c Royal Preston University Hospital   (United Kingdom)

^d UNIVERSITY OF YORK   (United Kingdom)

^e BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

^f PUBLIC HEALTH WALES   (United Kingdom)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cervical cancer; cervical intra epithelial neoplasia; human papilloma virus; incidence; screening; sexually transmitted disease

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHLAMYDIA; CONDYLOMA ACUMINATUM; DEMOGRAPHY; ECONOMIC ASPECT; FEMALE; GROUPS BY AGE; HERPES SIMPLEX; HUMAN; POLICY; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SOCIAL ASPECT; UNITED KINGDOM; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; EARLY DETECTION OF CANCER; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; WALES; YOUNG ADULT;

EID: 84861454283     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.148     Document Type: Article

References (27)

1. ACCS (2009) Re-examination of current policy on cervical screening for women aged 20-24 years. www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/ documents/digitalasset/dh-101366.pdf
2. Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, Dillner J, Tornberg S (2008) Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100(9): 622-629
3. Bauch CT, Li M, Chapman G, Galvani AP (2010) Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? Lancet Infect Dis 10(2): 133-137
4. Bernays RL, Kollias SS, Khan N, Brandner S, Meier S, Yonekawa Y (2002) Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 97(2): 354-362 (Pubitemid 34827336)
5. Bullard J, Coleman MP, Robinson D, Lutz JM, Bell J, Peto J (2000) Completeness of cancer registration: a new method for routine use Br J Cancer 82(5): 1111-1116 (Pubitemid 30128865)
6. Foley G, Alston R, Geraci M, Brabin L, Kitchener H, Birch J (2011) Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Br J Cancer 105(1): 177-184
7. Harper DM, Nieminen P, Paavonen J, Lehtinen M (2010) Cervical cancer incidence can increase despite HPV vaccination. Lancet Infect Dis 10(9): 594-595; author reply 595
8. IARC (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on Cervical Cancer Screening. Br Med J (Clin Res Ed) 293(6548): 659-664
9. Kitchener H (2011) STRATEGIes to increase Cervical screening uptake at first invitation (STRATEGIC): a cluster randomised trial. International Standard Randomised Controlled Trial Number (ISRCTN) Register, ISRCTN52303479. http://www.controlled-trials.com/ISRCTN52303479/
10. Lancucki L, Fender M, Koukari A, Lynge E, Mai V, Mancini E, Onysko J, Ronco G, Tornberg S, Vessey M, Patnick J (2010) A fall-off in cervical screening coverage of younger women in developed countries. J Med Screen 17(2): 91-96
11. NCI (2011a) Average Annual Percent Change (AAPC), Statistical Methodology and Applications Branch, National Cancer Institute. http://surveillance.cancer. gov/joinpoint/aapc.html
12. NCI (2011b) JoinPoint Regression Software. Statistical Methodology and Applications Branch, National Cancer Institute. http://surveillance.cancer.gov/ joinpoint/
13. NCIN (2011) Profile of Cervical Cancer in England: Incidence, Mortality and Survival, National Cancer Intelligence Network. http://www.ncin.org.uk/ publications/reports/default.aspx#type-specific
14. NHSCSP (2003) Modernising the NHSCSP: introduction of LBC and change in national policy. National Health Service Cervical Screening Programme (NHSCSP). http://www.cancerscreening.nhs.uk/cervical/news/009.html
15. NHSCSP (2008) NHS Cervical Screening Programme Annual Review 2008 (England) http://www.cancerscreening.nhs.uk/cervical/publications/2008review. html
16. NICE (2003) Technology Appraisal Guidance (TA69): Guidance on the use of liquid-based cytology for cervical screening: The National Institute for Health and Clinical Excellence (NICE), http://guidance.nice.org.uk/TA69
17. NICSP (2010) NI Cancer Screening Programmes: Changes to the cervical screening policy. http://www.cancerscreening.hscni.net/cervical/08- HCERVICALWHATSNEW.html#P7-233
18. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Elanko N, Coleman D, Yule R, Desai M (2004a) Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 91(5): 942-953 (Pubitemid 39273789)
19. Peto J, Gilham C, Fletcher O, Matthews FE (2004b) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364(9430): 249-256 (Pubitemid 38942814)
20. Rieck GC, Tristram A, Hauke A, Fielder H, Fiander AN (2006) Cervical screening in 20-24-year olds. J Med Screen 13(2): 64-71; discussion 62-3
21. Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC (2008) Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 98(10): 1704-1709 (Pubitemid 351684674)
22. Sasieni P, Adams J, Cuzick J (2003) Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 89(1): 88-93 (Pubitemid 36897941)
23. Sasieni P, Castanon A, Cuzick J (2009) Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. Br Med J 339: b2968
24. Sasieni P, Castanon A, Cuzick J (2010) The impact of cervical screening on young women: A critical review of the literature. In NHSCSP Publication 31. http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp31.html
25. Sasieni PD, Cuzick J, Lynch-Farmery E (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73(8): 1001-1005 (Pubitemid 26116757)
26. Sigurdsson K, Sigvaldason H (2007) Is it rational to start population-based cervical cancer screening at or soon after age 20? Analysis of time trends in preinvasive and invasive diseases. Eur J Cancer 43(4): 769-774 (Pubitemid 46502905)
27. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B (1993) Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation. Br J Cancer 67(2): 326-329 (Pubitemid 23049557)